Eidos Therapeutics Inc. (EIDX) Declined -5.8% or -0.77 To Price $12.51 On Thursday


Eidos Therapeutics Inc. (EIDX) declined -5.8% or -0.77 to $12.51. It is close to 128533 shares traded, which is 60.66% compare to the average total volume 211877. The market cap of EIDX is $459.77 million. The year to date change is -48.36%. The 52 week price range is from $11.38 to $24.75. Price of EIDX have changed 9.84% during last week. It have changed -22.75% over last month, -42.56% over last 3 months, -42.56% over last 6 months and -42.56% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EIDX is 17.57. It is 40.45% above current price. The 52-week High is 24.75. It is 97.84% from the current price. The 52-week Low is 11.38. It is -9.03% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of EIDX is 7.08 on 2018-08-15. Short % to float is 1.60%. There are some statistics of EIDX. It is has market cap $459.77 million. The share outstanding is 36.75 million. The average volume is 211877. The percent of top 15 Institution holding is 19.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EIDX is -19.63%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EIDX is -19.00%.


Tags:

Share this post